Skip to content

A Healthcare Economic Study of the Click Sexual Health Test

A Healthcare Economic Study of the Click Sexual Health Test

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04099199
Acronym
HERO
Enrollment
59
Registered
2019-09-23
Start date
2019-12-03
Completion date
2021-03-29
Last updated
2021-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexually Transmitted Diseases

Brief summary

This is a multicenter study with a minimum of three CLIA-Waived intended operator sites in which prospectively collected vaginal swab specimens will be evaluated with the Click Sexual Health Test as compared to standard of care. The specimen collection will occur over one study visit for each enrolled subject, but study staff will continue to follow the subject through standard of care until the subject receives treatment or she is lost to follow up.

Interventions

The Click Diagnostics device is a single-use (disposable), fully integrated, rapid, compact, device containing a polymerase chain reaction (PCR)-based nucleic acid amplification test (NAAT) for accurate, qualitative detection and differentiation of deoxyribonucleic acid (DNA) for Neisseria gonorrhea (NG), Trichomonas vaginalis (TV), and Chlamydia trachomatis (CT) organisms.

Sponsors

Visby Medical
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
14 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Documentation that the subject has provided informed consent prior to conducting study procedures * Subject is symptomatic or asymptomatic for sexually transmitted infections * Subject is female and 14 years of age or older at the time of enrollment * Able and willing to follow study procedures

Exclusion criteria

* Subject has been previously enrolled in the study * Subject has a contraindication, medical condition, serious intercurrent illness or other circumstance that in the investigator's judgement, could jeopordize the subject's safety or could interfere with the study procedures * Use of antiperspirants and deodorants or the following vaginal products: douches, washes, lubricants, vaginal wipes, vaginal moisturizers, or feminine hygiene spray in the genital area, within 48 hours prior to enrollment.

Design outcomes

Primary

MeasureTime frameDescription
Benefits of the Click Device for the detection of CT, NG, and TV in self-collected vaginal specimens as compared to standard of careup to 1 month
Costs of the Click Device for the detection of CT, NG, and TV in self-collected vaginal specimens as compared to standard of careup to 1 month
Cost-effectiveness of the Click Device for the detection of CT, NG, and TV in self-collected vaginal specimens as compared to standard of careup to 1 month
Preferences of the Click Device for the detection of CT, NG, and TV in self-collected vaginal specimens as compared to standard of careup to 1 month
Usability of the Click Device for the detection of CT, NG, and TV in self-collected vaginal specimens as compared to standard of careup to 1 month
Accuracy of treatment/no treatment decisions in light of the outcomes of testing for CT, NG, and TV infections by Click device as compared to standard of careup to 1 month
Usability and Satisfaction will be measured by 5-point Likert scale responses, yes/no questions, and open-text questions from study subjects, study operators, and healthcare providers.up to 1 monthThe scale measures responses to questions in the form of: (1) Strongly Disagree, (2) Disagree, (3) Neutral, (4) Agree, and (5) Strongly agree.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026